NEW YORK, Feb. 1, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial
markets for 10,000 U.S. and global securities, congratulates True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (OTCQB:
TRLFF), the first Canadian-listed company, to conduct a successful Regulation A+ offering on its OTCQB Venture market.
The company's common stock began trading on the OTCQB market on July 20, 2017. U.S. investors
can find current financial disclosure and Real-Time Level 1 quotes for the Company on www.otcmarkets.com.
"We congratulate True Leaf on a successful Reg A+ offering and the expansion of its unique profile to a broader pool of
American investors," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC
Markets Group. "True Leaf's $14 million (CAD) Reg A+ offering and private placement demonstrate the
quality and effectiveness of both our premium OTCQX and OTCQB Venture markets in facilitating an effective capital raise. This
presents tremendous benefits for small-cap, entrepreneurial and emerging sector companies seeking to raise capital--tailoring the
needs of being a public company, while providing a cost-effective, less burdensome alternative to a national exchange
listing."
"Access to US investors at an attractive cost through Reg A+ is a key advantage for Canadian reporting issuers," said
Richard Carleton, CEO of the Canadian Securities Exchange where True Leaf is listed in
Canada. "The True Leaf Reg A+ financing should serve as an important model for their peers."
The OTCQB Venture Market is designed for early-stage and developing U.S. and international companies. To be eligible,
companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification
and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the
technology and regulation to improve the information and trading experience for investors.
About True Leaf
Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. The Company's goal
is to provide federally-approved cannabis products that will be sold across Canada and
the United States. True Leaf Medicine Inc. was launched in July
2013 to become a licensed producer of medicinal cannabis for the Canadian market. True Leaf Medicine Inc. has been given
approval by Health Canada to build its grow facility and will be subject to a Health Canada security inspection upon completion
to allow for the cultivation, manufacture, and distribution of cannabis products. Currently, True Leaf does not have a license to
produce cannabis.
Established in 2015, True Leaf Pet Inc. markets hemp-focused products for the pet industry. The Company launched the True
Hemp™ pet supplement line in Canada, the United States, and
Europe, becoming one of the first hemp-based pet product lines to be marketed worldwide. True
Hemp™ North American products are free of CBD and THC, making them the first federally legal products to be marketed in
Canada and the United States.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink®
Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers
that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and
empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
View original content with multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-marks-first-canadian-listed-regulation-a-offering-on-its-otcqb-venture-market-300591936.html
SOURCE OTC Markets Group Inc.